Each Cryos NY donor candidate meets a rigorous selection criteria and undergoes a thorough medical examination prior to acceptance. Donors are tested and approved according to at least one Standard, but often more.

According to the US Food and Drug Administration and the New York State Department of Health, all Cryos NY samples are kept in quarantine for 6-months before being released for sale. Donors are screened by a doctor for infectious diseases at 3-month intervals. If a donor is tested positive, his samples are destroyed.

Yes, Cryos NY screens all of its donors for the 97 most common mutations of Cystic Fibrosis. See also Screening.

Cystic Fibrosis (CF) is one of the most common recessive genetic disorders within the caucasian (white) population. Approximately, 3% of the population are carriers of the CF gene. Both the male and the female must be carriers to yield a 25% risk of having a child with CF. Of this risk, approximately 50% of the children are healthy carriers and 25% are healthy non-carriers.

If only one of the parents is a carrier, the child cannot develop CF.

The female recipient can be examined by a blood sample. If the recipient is negative, the child cannot develop CF.

It is Cryos NY's policy to keep the risk for the transmission of inherent diseases by donor insemination below the risk in the average population. If certain genetic screening is common among family planning within society, it should also be a part of Cryos NY's screening process. However, Cryos NY cannot guarantee a 0% risk factor with respect to the transmission of inherent diseases.

Cryos NY requires its donors to complete a detailed medical history (covering immediate family members) to be analyzed and reviewed by its Medical Director. Furthermore, Cryos NY performs the following genetic tests on all of its American donors:

1. Cystic Fibrosis - 97 Most Common Mutation Analysis
2. Karyotype (46, XY) - To determine the normal set of chromosomes
   

According to the specific donors race and ethnicity, below you will find the additional genetic testing performed on American donors:

As Cryos NY distributes donor semen globally, it screens donors according to the regulations on where the semen will be used for artificial insemination. See under Donor Screening.

Cryos NY screens its American donors for CMV which includes IgG and IgM. Donors are screened for CMV (IgG and IgM) prior to specimens entering the 6-month quarantine period as well as at the completion of the 6-month quarantine period. As Cryos NY donors are required to donate at least 1-2 times per week, donors will have specimens entering into quarantine approximately every 3-months. Therefore, donors will be screened for CMV every 3-months. 

Cryos NY's Screening Policy for American donors includes testing for genetic disorders as well as communicable diseases. Additional testing will be performed for donors of at risk ethnicities such as donors descending from Mediterranean countries, Eastern European countries, races such as African Americans and religious faiths such as Ashkenazi Jewish.